Status:
COMPLETED
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis
Lead Sponsor:
Dow Pharmaceutical Sciences
Conditions:
Onychomycosis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and effectiveness of two concentrations of IDP-108 in treating patients with onychomycosis
Eligibility Criteria
Inclusion
- Presence of onychomycosis of the target toenail
- A positive fungal culture from the target toenail
Exclusion
- Any disease or condition that might cause nail abnormalities or may interfere with clinical evaluations
- Presence of tinea pedis (athletes foot)
- Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00777868
Start Date
October 1 2007
End Date
April 1 2009
Last Update
June 22 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad de Investigación en Salud
Chihuahua City, Chihuahua, Mexico, CP31205
2
Clinical Research Institute
Mexico City, Federal District, Mexico, CP54055
3
Hospital Central Militar
Mexico City, Federal District, Mexico
4
Hospital General de México
México, Federal District, Mexico, CP 06726